Letter: ACE2, IBD and COVID‐19—why IBD patients may be at reduced risk of COVID‐19

LINKED CONTENT This article is linked to Taxonera et al paper. To view this article, visit https://doi.org/10.1111/apt.15804

Na minha lista:
書目詳細資料
發表在:Aliment Pharmacol Ther
Main Authors: Prentice, Ralley E., Tjandra, Doug, Garg, Mayur, Lubel, John S., Fourlanos, Spiros, Johnson, Doug, Al‐Ani, Aysha, Christensen, Britt
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2020
主題:
Letters to the Editors
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537250/
https://ncbi.nlm.nih.gov/pubmed/33105980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.16063
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍